Prerna Goyal
Overview
Explore the profile of Prerna Goyal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goyal M, Goyal O, Goyal P, Sood A
Indian J Gastroenterol
. 2024 Nov;
PMID: 39565451
No abstract available.
2.
Goyal O, Goyal P, Kishore H, Kaur J, Kumar P, Sood A
Indian J Gastroenterol
. 2022 Feb;
41(4):378-388.
PMID: 35188623
Background/purpose: Patients with functional dyspepsia (FD) have poor health-related quality of life (HRQOL), but Indian data are lacking. Also, there is non-availability of validated disease-specific questionnaire to assess HRQOL in...
3.
Goyal O, Nohria S, Dhaliwal A, Goyal P, Soni R, Chhina R, et al.
Indian J Gastroenterol
. 2021 Dec;
40(6):646-647.
PMID: 34902104
No abstract available.
4.
Goyal O, Nohria S, Batta S, Dhaliwal A, Goyal P, Sood A
J Gastroenterol Hepatol
. 2021 Sep;
37(2):301-309.
PMID: 34555865
Background And Aim: Prospective trials evaluating efficacy of specific diet restriction in functional dyspepsia (FD) are scarce. We aimed to assess efficacy of low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols...
5.
Goyal O, Batta S, Nohria S, Kishore H, Goyal P, Sehgal R, et al.
J Gastroenterol Hepatol
. 2021 Jan;
36(8):2107-2115.
PMID: 33464683
Background And Aim: Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol (FODMAP) diet improves irritable bowel syndrome (IBS) symptoms. Data on long-term "modified" FODMAP diet are emerging. We aimed to assess...
6.
Goyal O, Nohria S, Goyal P, Kaur J, Sharma S, Sood A, et al.
Sci Rep
. 2020 Dec;
10(1):21117.
PMID: 33273703
Saroglitazar, a dual peroxisome proliferator activated receptor α/γ agonist, approved for diabetic dyslipidemia (DD), is potential therapeutic option for non-alcoholic fatty liver disease (NAFLD). This prospective, observational, real-world study aimed...
7.
Goyal O, Nohria S, Dhaliwal A, Goyal P, Soni R, Chhina R, et al.
Indian J Gastroenterol
. 2020 Nov;
40(2):144-153.
PMID: 33226570
Background/purpose: There is scarcity of data on prevalence, overlap, and risk factors for functional gastrointestinal disorders (FGID) by Rome IV criteria. We evaluated these factors among medical, nursing, and humanities...
8.
Goyal P, Goyal O, Chhina R
J Assoc Physicians India
. 2020 Jan;
68(1):97.
PMID: 31979903
No abstract available.
9.
Goyal O, Bansal A, Goyal P
J Assoc Physicians India
. 2017 Jun;
65(5):105-106.
PMID: 28598064
Emphysematous gastritis is a rare but severe form of phlegmonous gastritis caused by gastric mucosal disruption and infection of stomach wall by gas-forming bacteria. Ingestion of corrosive substances is the...
10.
Goyal O, Singh T, Singh R, Goyal P, Chhina R
J Assoc Physicians India
. 2014 Oct;
62(1):84-6.
PMID: 25327108
No abstract available.